It is normal for two illnesses symptoms to overlap but if both have been correctly diagnosed choosing a course of therapy is ...

Drug-induced liver injury (DILI) is a significant concern in clinical practice, arising from medications, herbs, and dietary ...

A young woman with three kids died within 18 days of being diagnosed with bile duct cancer, which the doctors initially ...

Hepatic biliary adenofibroma (BAF) is a rare benign bile duct neoplasm that has garnered increasing attention due to its potential role as a precursor lesion for intrahepatic cholangiocarcinoma (iCCA) ...

Bile reflux gastritis (BRG) is a gastro-intestinal condition especially characterized by the reflux of bile into the stomach, further leading to mucosal inflammation along with various other clinical ...

Doing something audaciously bold is said to take gall. The saying comes from the word “gall,” referring to bile — in reality, ...

Phase 1a study will evaluate single and multiple ascending doses of ABI-6250 in healthy participants with data expected in Q3 2025 –– Biomarker ...

Penn undergraduates won $10,000 in the 2025 Y-Prize competition with their proposal for an adjustable bile duct technology that maintains bile flow without the need for additional surgeries.

Intrahepatic cholangiocarcinoma (iCCA) can originate from the large bile duct group (segment bile ducts and area bile ducts), ...

Assembly Biosciences (ASMB) announced that the first participant has been dosed in the Phase 1a trial of ABI-6250, the company’s orally ...

Ctexli’s approval further entrenches Mirum as a leader in rare liver diseases, alongside its cornerstone product Livmarli and ...